Catalyst Wire Dossier Catalyst Wire Dossier

Self-amplifying mRNA influenza vaccine (experimental)

self-amplifying mRNA influenza vaccine · Seqirus
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Self-amplifying mRNA influenza vaccine (experimental), covering 2024-11-27 to 2024-11-27. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Reactogenicity, and Immunogenicity Study of a Self-Amplifying MRNA Influenza Vaccine in Healthy Adults [Phase 1]

See pricing